KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Prepaid Assets (2016 - 2025)

Acadia Pharmaceuticals has reported Prepaid Assets over the past 16 years, most recently at $59.5 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $59.5 million for Q4 2025, up 6.91% from a year ago — trailing twelve months through Dec 2025 was $59.5 million (up 6.91% YoY), and the annual figure for FY2025 was $59.5 million, up 6.91%.
  • Prepaid Assets for Q4 2025 was $59.5 million at Acadia Pharmaceuticals, down from $60.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for ACAD hit a ceiling of $60.9 million in Q3 2025 and a floor of $21.0 million in Q2 2022.
  • Median Prepaid Assets over the past 5 years was $33.2 million (2021), compared with a mean of $37.0 million.
  • Biggest five-year swings in Prepaid Assets: fell 20.05% in 2022 and later surged 92.74% in 2024.
  • Acadia Pharmaceuticals' Prepaid Assets stood at $23.9 million in 2021, then dropped by 10.44% to $21.4 million in 2022, then soared by 82.69% to $39.1 million in 2023, then surged by 42.44% to $55.7 million in 2024, then rose by 6.91% to $59.5 million in 2025.
  • The last three reported values for Prepaid Assets were $59.5 million (Q4 2025), $60.9 million (Q3 2025), and $52.7 million (Q2 2025) per Business Quant data.